Latest filing published 16 Feb 2022 for BALCHEM CORP, €43k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James C. Hyde: trading record in brief
James C. Hyde (chief executive) discloses dealings in Balchem Corp to SEC (Form 4). We count 5 filings; the first trade dates from 10 February 2022 and the latest from 15 February 2022.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 16 February 2022 came the latest disclosure, a share grant for €43k in Balchem Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James C. Hyde
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 348 shares@ US$139.3852.7% of flowCommon StockSEC:0001140361-22-005746:0
- 318 shares@ US$137.7347.3% of flowCommon StockSEC:0001140361-22-005594:0
- 820 shares0Common StockSEC:0001140361-22-005092:0
3 of 3 declarations
